The observed percentage of CD31+ cells in adenocarcinoma specimens was twice that of controls (14.59%, P < 0.05), and it was significantly increased in comparison with the percentage of CD31+ cells observed in UC tissues (Figure 9, Table 2). The gene discussed is PECAM1; the disease is adenocarcinoma.